Dr. Misbahuddin Syed, MD

Dr. Syed practices at H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida.

Dr. Syed's NPI, 1962848994, was assigned on May 16, 2013. Dr. Syed graduated from USF Health Morsani College of Medicine in 2013. Dr. Syed holds Florida license ME128558.

Dr. Syed's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD, at 10901 McKinley Dr, Tampa, FL 33612.

Dr. Syed's primary practice is H Lee Moffitt Cancer Center & Research Institute I - HOPD in Tampa, Florida. Dr. Syed is also affiliated with Moffitt Cancer Hospital. The medical group on file is Moffitt Cancer Center. Dmand AI also links Dr. Syed to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Syed practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Syed's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Syed is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Syed's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists acute respiratory failure, atherosclerosis, cardiac arrhythmia, cellulitis, collapsed lung, electrolyte disorders, gastrointestinal bleeding and gastrointestinal infection among the conditions Dr. Syed treats.

CMS data shows 386 Medicare services from Dr. Syed across 2 procedure codes in 2024, for 126 Medicare patients. Medicare paid $26,128 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 126 Medicare patients who saw Dr. Syed in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Syed's median patient age at 68, with 48% women.

In 2024, Dr. Syed wrote 34 Medicare Part D claims for 13 patients. 44% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $60 in total drug cost. In 2021, CMS named 28 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Syed for performance year 2024, reported as part of a group. Dr. Syed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 10 papers to Dr. Syed, published from 2020 to 2025. 2020 was the busiest year, with 2. The most frequent topics are COVID-19 and Immunocompromised Host. Dr. Syed has published most often in Postgrad Med J. Dr. Syed's most frequent co-authors are Naser Ahsan Shareef, DO, Timothy N. Hembree, DO and Dinesh Keerty, MD.

CMS Open Payments shows 35 general payments to Dr. Syed from 8 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 88% of the total. Astellas Pharma US Inc paid the most, $419.

Dr. Syed graduated from USF Health Morsani College of Medicine in 2013.

Dr. Syed is in network with 5 carriers, including Excellus BlueCross BlueShield, Molina and United Healthcare. HMO plans come from the most carriers, 4. Check the plan with the practice before a visit.